LLY · Stock research · Public disclosure research

LLY — Eli Lilly & Co: Insider & Congressional Trading Activity

Data as of Jun 16, 2026. Collected disclosures, not exhaustive history.

30-day and 12-month windows end Oct 15, 2026 and use transaction dates, not disclosure dates. The data-as-of date above reflects the latest collected disclosure and may be older than the window end.

Insider buys · 30d0Collected open-market purchases
Insider sales · 30d0Collected sales
Net reported value · 30d$0.00Reported purchase value less reported sale value, trailing 30 days.
Congressional trades · 12m0By trade date; latest collected disclosure: —
Latest filing on recordForm 4Filed Jun 16, 2026

Short-interest snapshot

View settlement history →
Short interest · shares7,035,434Settlement: Sep 30, 2026
SI % · shares outstanding0.7474%Settlement: Sep 30, 2026
Days to cover2.93 daysSettlement: Sep 30, 2026
Change · shares-484,484Settlement: Sep 30, 2026Prior settlement: Sep 15, 2026
Change · percent-6.4427%Settlement: Sep 30, 2026Prior settlement: Sep 15, 2026

FINRA short interest via Polygon. Updated Oct 13, 2026. Changes compare the displayed settlement with the prior settlement, not daily trading activity.

SI % uses shares outstanding available at enrichment time, not historical shares-outstanding counts. It is not a percentage of float. Missing percentages remain not reported; no shares-outstanding lookup is performed on page render.

Recent insider transactions

View all insider transactions →
Up to five collected transactions, prioritizing open-market purchases and sales. Open-market purchases and sales appear first by default, newest first within each group. Values are reported, not estimates. Derivative transactions are labeled separately.
Yuffa IlyaEVP&Pres, LLY USA&Global CapabOpen-market saleNon-derivative security10b5-1 plan indicated2,500$1,150.77$2,876,925.0029,804.111Jun 10, 2026Jun 11, 2026SEC filing
Fyrwald J ErikDirectorGrant / awardNon-derivative security10b5-1 plan not indicated8.7809$1,129.35$9,916.7175,401.0968Jun 15, 2026Jun 16, 2026SEC filing
LUCIANO JUAN RDirectorGrant / awardNon-derivative security10b5-1 plan not indicated14.0937$1,129.35$15,916.7216,890.7141Jun 15, 2026Jun 16, 2026SEC filing
Sulzberger GabrielleDirectorGrant / awardNon-derivative security10b5-1 plan not indicated4.3904$1,129.35$4,958.302,995.3956Jun 15, 2026Jun 16, 2026SEC filing
Alvarez RalphDirectorGrant / awardNon-derivative security10b5-1 plan not indicated10.9945$1,129.35$12,416.6455,723.4672Jun 15, 2026Jun 16, 2026SEC filing

Read the disclosure, then the context

Insider data covers the trailing 12 months on public tables. Congressional tables cover all saved disclosures. Neither is an exhaustive history. Form 4 filing dates and congressional disclosure dates may differ from trade dates. Congressional amounts are ranges, not estimated dollar totals. Disclosure activity alone does not establish intent or predict returns.

From disclosure to research

Keep LLY on your research desk.

Create a workspace for filing analysis and research notes. Filing-alert availability depends on your plan. Review the plan features separately; opening the plans page does not create an alert.